In the Andrews Medical Device Litigation Reporter 2007, Foley Partner Sharie Brown comments how medical device companies must review their operations for corruption risk and develop policies that help prevent, detect and punish those who make or attempt to make corrupt payments to foreign officials on the company’s behalf.
Related Insights
16 January 2025
Blogs
Final Regulations for New Clean Energy Production and Investment Tax Credits
16 January 2025
Health Care Law Today
DEA Tightens Buprenorphine Telemedicine Prescribing Rules
The Drug Enforcement Administration and the U.S. Department of Health & Human Services just finalized their March 2023 proposed rule regarding telemedicine prescribing of buprenorphine.
16 January 2025
Innovative Technology Insights
President Biden Issues Second Cybersecurity Executive Order
This executive order builds upon EO 14028 to modernize the federal government’s cybersecurity posture while expanding on requirements imposed on third-party suppliers.